Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned mouse

Brain Research

Volumn 1386, Issue , 2011, Pages 70-80

  Smith, Beth A ^a   Goldberg, Natalie R S ^b   Meshul, Charles K ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Dopamine; Dopamine transporter; Exercise; MPTP; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; TREADMILL EXERCISE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; EXERCISE TEST; EXERCISE THERAPY; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEURAL PATHWAYS; PHYSICAL CONDITIONING, ANIMAL; PRESYNAPTIC TERMINALS; RECOVERY OF FUNCTION; SUBSTANTIA NIGRA;

MUS;

EID: 79953908283     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.02.003     Document Type: Article

References (57)

1. Al-Jarrah, M., Pothakos, K., Novikova, L., Smirnova, I.V., Kurz, M.J., Stehno-Bittel, L., Lau, Y.S., 2007. Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of parkinsonism with severe neurodegeneration. Neuroscience 149, 28-37. (Pubitemid 47488652)
2. Amende, I., Kale, A., McCue, S., Glazier, S., Morgan, J.P., Hampton, T.G., 2005. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J. Neuroeng. Rehabil. 2, 20.
3. Aponso, P.M., Faull, R.L., Connor, B., 2008. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Neuroscience 151, 1142-1153.
4. Baquet, Z.C., Williams, D., Brody, J., Smeyne, R.J., 2009. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6 J mouse. Neuroscience 161, 1082-1090.
5. Benes, F.M., Lange, N., 2001. Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci. 24, 11-17. (Pubitemid 32332892)
6. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F., 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20, 415-455.
7. Blume, S.R., Cass, D.K., Tseng, K.Y., 2009. Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism. Exp. Neurol. 19, 19.
8. Chu, P.-W., Seferian, K.S., Birdsall, E., Truong, J.G., Riordan, J.A., Metcalf, C.S., Hanson, G.R., Fleckenstein, A.E., 2008. Differential regional effects of methamphetamine on dopamine transport. Euro. J. Pharm. 590 (103), 105-110.
9. Clarke, P.G., 1992. How inaccurate is the Abercrombie correction factor for cell counts? Trends Neurosci. 15, 211-212.
10. Crabbe, J.C., Metten, P., Yu, C.H., Schlumbohm, J.P., Cameron, A.J., Wahlsten, D., 2003. Genotypic differences in ethanol sensitivity in two tests of motor incoordination. J. Appl. Physiol. 95, 1338-1351.
11. Dibble, L.E., Addison, O., Papa, E., 2009. The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum. J. Neurol. Phys. Ther. 33, 14-26.
12. Fertl, E., Doppelbauer, A., Auff, E., 1993. Physical activity and sports in patients suffering from Parkinson's disease in comparison with healthy seniors. J. Neural Transm. Park. Dis. Dement. Sect. 5, 157-161.
13. Finkelstein, D.I., Stanic, D., Parish, C.L., Tomas, D., Dickson, K., Horne, M.K., 2000. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97, 99-112. (Pubitemid 30195880)
14. Fisher, B.E., Petzinger, G.M., Nixon, K., Hogg, E., Bremmer, S., Meshul, C.K., Jakowec, M.W., 2004. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse basal ganglia. J. Neurosci. Res. 77, 378-390.
15. Fisher, B.E., Wu, A.D., Salem, G.J., Song, J., Lin, C.H., Yip, J., Cen, S., Gordon, J., Jakowec, M., Petzinger, G., 2008. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. Arch. Phys. Med. Rehabil. 89, 1221-1229.
16. Fredriksson, A., Palomo, T., Chase, T., Archer, T., 1999. Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists. J. Neural Transm. 106, 283-300. (Pubitemid 29196932)
17. Frielingsdorf, H., Schwarz, K., Brundin, P., Mohapel, P., 2004. No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA 101, 10177-10182.
18. Gerecke, K.M., Jiao, Y., Pani, A., Pagala, V., Smeyne, R.J., 2010. Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res. 1341, 72-83.
19. Goldberg, N. R. S., Haack, A. K., and Meshul, C. K., in press. Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease. Neuroscience 2010, 8.
20. Guillot, T.S., Asress, S.A., Richardson, J.R., Glass, J.D., Miller, G.W., 2008. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. J. Mot Behav. 40, 568-577.
21. Hawkes, C.H., Del Tredici, K., Braak, H., 2009. A timeline for Parkinson's disease. Parkinsonism Relat. Disord. 16, 79-84.
22. Holschneider, D.P., Yang, J., Guo, Y., Maarek, J.M., 2007. Reorganization of functional brain maps after exercise training: importance of cerebellar-thalamic-cortical pathway. Brain Res. 1184, 96-107. (Pubitemid 350160587)
23. Jackson-Lewis, V., Jakowec, M., Burke, R.E., Przedborski, S., 1995. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Neurodegeneration 4, 257-269.
24. Kamens, H.M., Crabbe, J.C., 2007. The parallel rod floor test: a measure of ataxia in mice. Nat. Protoc. 2, 277-281.
25. Kamens, H.M., Phillips, T.J., Holstein, S.E., Crabbe, J.C., 2005. Characterization of the parallel rod floor apparatus to test motor incoordination in mice. Genes Brain Behav. 4, 253-266. (Pubitemid 40799773)
26. Mabandla, M.V., Russell, V.A., 2010. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav. Brain Res. 211, 16-22.
27. Meredith, G.E., Kang, U.J., 2006. Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov. Disord. 21, 1595-1606.
28. Meredith, G.E., Totterdell, S., Beales, M., Meshul, C.K., 2009. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp. Neurol. 219, 334-340.
29. Mori, F., Nishie, M., Kakita, A., Yoshimoto, M., Takahashi, H., Wakabayashi, K., 2006. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J. Neuropathol. Exp. Neurol. 65, 808-815.
30. Nagai, T., McGeer, P.L., McGeer, E.G., 1983. Distribution of GABA-T-intensive neurons in the rat forebrain and midbrain. J. Comp. Neurol. 218, 220-238.
31. Nair-Roberts, R.G., Chatelain-Badie, S.D., Benson, E., White-Cooper, H., Bolam, J.P., Ungless, M.A., 2008. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 152, 1024-1031.
32. O'Dell, S.J., Gross, N.B., Fricks, A.N., Casiano, B.D., Nguyen, T.B., Marshall, J.F., 2007. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience 144, 1141-1151. (Pubitemid 46014003)
33. Paxinos, G., Franklin, K.B.J. (Eds.), 2004. The mouse brain in stereotaxic coordinates. 2nd ed. Gulf Professional Publishing.
34. Peng, J., Xie, L., Jin, K., Greenberg, D.A., Andersen, J.K., 2008. Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. Neuroscience 153, 664-670.
35. Petroske, E., Meredith, G.E., Callen, S., Totterdell, S., Lau, Y.S., 2001. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106, 589-601. (Pubitemid 32925247)
36. Petzinger, G.M., Walsh, J.P., Akopian, G., Hogg, E., Abernathy, A., Arevalo, P., Turnquist, P., Vuckovic, M., Fisher, B.E., Togasaki, D.M., Jakowec, M.W., 2007. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J. Neurosci. 27, 5291-5300.
37. Pothakos, K., Kurz, M.J., Lau, Y.S., 2009. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. BMC Neurosci. 10, 6.
38. Poulton, N.P., Muir, G.D., 2005. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats. Exp. Neurol. 193, 181-197.
39. Ridgel, A.L., Vitek, J.L., Alberts, J.L., 2009. Forced, not voluntary, exercise improves motor function in Parkinson's disease patients. Neurorehabil. Neural Repair 23, 600-608.
40. Robinson, S., Freeman, P., Moore, C., Touchon, J.C., Krentz, L., Meshul, C.K., 2003. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Exp. Neurol. 180, 74-87.
41. Salahpour, A., Ramsey, A.J., Medvedev, I.O., Kile, B., Sotnikova, T.D., Holmstrand, E., Ghisi, V., Nicholls, P.J., Wong, L., Murphy, K., Sesack, S.R., Wightman, R.M., Gainetdinov, R.R., Caron, M.G., 2008. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. PNAS 105 (11), 4405-4410. (Pubitemid 351754393)
42. Salvatore, M.F., Pruett, B.S., Spann, S.L., Dempsey, C., 2009. Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS ONE 4, e8466.
43. Sasco, A.J., Paffenbarger Jr., R.S., Gendre, I., Wing, A.L., 1992. The role of physical exercise in the occurrence of Parkinson's disease. Arch. Neurol. 49, 360-365.
44. Schang, A.Y., Fisher, B.E., Sashkin, N.R., Moore, C., Dirling, L.B., Petzinger, G.M., Jakowec, M.W., Meshul, C.K., 2010. Correlates and analysis of motor function in humans and animal models of Parkinson's disease. In: Raber, J. (Ed.), Neuromethods: Behavioral Analysis. Humana Press, Inc., Totawa, Japan, pp. 55-90.
45. Sedelis, M., Schwarting, R.K., Huston, J.P., 2001. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain Res. 125, 109-125.
46. Smolen, A.J., Wright, L.L., Cunningham, T.J., 1983. Neuron numbers in the superior cervical sympathetic ganglion of the rat: a critical comparison of methods for cell counting. J. Neurocytol. 12, 739-750. (Pubitemid 13022004)
47. Steiner, B., Winter, C., Hosman, K., Siebert, E., Kempermann, G., Petrus, D.S., Kupsch, A., 2006. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp. Neurol. 199, 291-300.
48. Tande, D., Hoglinger, G., Debeir, T., Freundlieb, N., Hirsch, E.C., Francois, C., 2006. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 129, 1194-1200.
49. Thacker, E.L., Chen, H., Patel, A.V., McCullough, M.L., Calle, E.E., Thun, M.J., Schwarzschild, M.A., Ascherio, A., 2008. Recreational physical activity and risk of Parkinson's disease. Mov. Disord. 23, 69-74.
50. Tillerson, J.L., Caudle, W.M., Reveron, M.E., Miller, G.W., 2002. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Exp. Neurol. 178, 80-90.
51. Tillerson, J.L., Caudle, W.M., Reveron, M.E., Miller, G.W., 2003. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119, 899-911. (Pubitemid 36694814)
52. Tillerson, J.L., Miller, G.W., 2003. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J. Neurosci. Meth. 123, 189-200.
53. Tomac, A., Lindqvist, E., Lin, L.F., Ogren, S.O., Young, D., Hoffer, B.J., Olson, L., 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
54. Unal-Cevik, I., Kilinc, M., Gursoy-Ozdemir, Y., Gurer, G., Dalkara, T., 2004. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res. 1015, 169-174. (Pubitemid 38829751)
55. van Praag, H., Christie, B.R., Sejnowski, T.J., Gage, F.H., 1999a. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA 96, 13427-13431.
56. van Praag, H., Kempermann, G., Gage, F.H., 1999b. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 2, 266-270.
57. Yoon, M.C., Shin, M.S., Kim, T.S., Kim, B.K., Ko, I.G., Sung, Y.H., Kim, S.E., Lee, H.H., Kim, Y.P., Kim, C.J., 2007. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Neurosci. Lett. 423, 12-17.